Related references
Note: Only part of the references are listed.Distribution of amyloid precursor protein and amyloid-β immunoreactivity in DBA/2J glaucomatous mouse retinas
David Goldblum et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers
S Florent et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Pain: Moving from symptom control toward mechanism-specific pharmacologic management
CJ Woolf
ANNALS OF INTERNAL MEDICINE (2004)
Endoplasmic reticulum-localized amyloid β-peptide is degraded in the cytosol by two distinct degradation pathways
A Schmitz et al.
TRAFFIC (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Glaucoma: Ocular Alzheimer's disease?
SJ McKinnon
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Co-incorporation of Aβ40 and Aβ42 to form mixed pre-fibrillar aggregates
D Frost et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
KN Dahlgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
